PETS - PetMed Express Inc Stock Price, Fair Value and News

4.13USD-0.02 (-0.48%)Market Closed

Market Summary

USD4.13-0.02

Market Closed

-0.48%

PETS Stock Price

View Fullscreen

PETS RSI Chart

PETS Valuation

Market Cap

87.0M

Price/Earnings (Trailing)

-10.76

Price/Sales (Trailing)

0.31

EV/EBITDA

-11.96

Price/Free Cashflow

50.42

PETS Price/Sales (Trailing)

PETS Profitability

EBT Margin

-3.36%

Return on Equity

-8.08%

Return on Assets

-4.66%

Free Cashflow Yield

1.98%

PETS Fundamentals

PETS Revenue

Revenue (TTM)

277.0M

Rev. Growth (Yr)

10.95%

Rev. Growth (Qtr)

-8%

PETS Earnings

Earnings (TTM)

-8.1M

Earnings Growth (Yr)

-10.6K%

Earnings Growth (Qtr)

-2.8K%

Breaking Down PETS Revenue

Last 7 days

-2.1%

Last 30 days

-13.2%

Last 90 days

-39.7%

Trailing 12 Months

-72.8%

How does PETS drawdown profile look like?

PETS Financial Health

Current Ratio

1.32

PETS Investor Care

Dividend Yield

21.9%

Dividend/Share (TTM)

0.9

Shares Dilution (1Y)

0.40%

Diluted EPS (TTM)

-0.4

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	256.9M	264.9M	270.5M	277.0M
2022	273.4M	264.3M	262.3M	260.5M
2021	309.2M	292.3M	284.3M	279.1M
2020	284.1M	300.3M	305.8M	311.8M
2019	283.4M	276.0M	274.6M	274.4M
2018	273.8M	281.5M	286.2M	286.2M
2017	249.2M	256.3M	262.3M	269.5M
2016	234.7M	235.5M	239.6M	241.5M
2015	229.4M	228.5M	227.6M	229.3M
2014	233.4M	231.7M	228.8M	228.0M
2013	227.8M	233.1M	235.4M	235.9M
2012	238.3M	233.6M	233.5M	232.6M
2011	231.6M	230.9M	227.8M	233.2M
2010	238.3M	236.6M	235.0M	233.3M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of PetMed Express Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Dec 11, 2023	moseley mark bradley jr	acquired	99,960	7.14	14,000	-
Nov 09, 2023	fulgoni gian	bought	301,124	7.3445	41,000	-
Nov 03, 2023	chambers christine	bought	50,006	7.26	6,888	cfo
Nov 03, 2023	hulett mathew n	bought	100,551	7.26	13,850	ceo & president
Aug 14, 2023	smith jacqueline paula	acquired	-	-	6,000	-
Aug 03, 2023	campbell leslie c.g.	acquired	-	-	7,500	-
Aug 03, 2023	purcel diana g	acquired	-	-	7,500	-
Aug 03, 2023	campos sandra yvette	acquired	-	-	7,500	-
Aug 03, 2023	fulgoni gian	acquired	-	-	7,500	-
Jun 15, 2023	chambers christine	acquired	-	-	11,750	cfo

Which funds bought or sold PETS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Global Retirement Partners, LLC	sold off	-100	-120	-	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-61.04	-11,000	3,000	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	-27,911	78,443	-%
Apr 19, 2024	Cutler Group LLC / CA	new	-	1,000	1,000	-%
Apr 18, 2024	Aspire Private Capital, LLC	unchanged	-	-1,318	2,280	-%
Apr 18, 2024	Oak Thistle LLC	new	-	50,304	50,304	0.04%
Apr 17, 2024	PEOPLES FINANCIAL SERVICES CORP.	sold off	-100	-7,560	-	-%
Apr 11, 2024	Profit Investment Management, LLC	reduced	-47.2	-917,331	461,105	0.26%
Apr 05, 2024	CWM, LLC	added	68.77	1,000	27,000	-%
Apr 05, 2024	GAMMA Investing LLC	unchanged	-	-67.00	225	-%

Are Funds Buying or Selling PETS?

Are funds buying PETS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PETS

No. of Funds

Unveiling PetMed Express Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	5.57%	1,177,259	SC 13G/A
Feb 13, 2024	renaissance technologies llc	6.36%	1,344,284	SC 13G
Jan 25, 2024	blackrock inc.	8.4%	1,779,658	SC 13G/A
Jul 07, 2023	blackrock inc.	8.0%	1,694,462	SC 13G/A
Feb 09, 2023	vanguard group inc	7.04%	1,483,238	SC 13G/A
Jan 26, 2023	proshare advisors llc	3.2%	649,277	SC 13G/A
Jan 23, 2023	blackrock inc.	16.5%	3,473,358	SC 13G/A
Jan 27, 2022	blackrock inc.	15.7%	3,290,803	SC 13G/A
Jan 26, 2022	blackrock inc.	15.7%	3,290,803	SC 13G
Feb 11, 2021	renaissance technologies llc	6.21%	1,258,073	SC 13G/A

Recent SEC filings of PetMed Express Inc

View All Filings

Date Filed	Form Type	Document
Apr 15, 2024	8-K	Current Report
Apr 15, 2024	10-Q/A	Quarterly Report
Apr 15, 2024	10-Q/A	Quarterly Report
Apr 15, 2024	10-Q	Quarterly Report
Apr 15, 2024	10-K/A	Annual Report
Feb 15, 2024	8-K	Current Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	SC 13G	Major Ownership Report
Feb 09, 2024	NT 10-Q	NT 10-Q
Feb 08, 2024	8-K	Current Report

Peers (Alternatives to PetMed Express Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	357.8B	85.2B	-4.29%	-10.06%	10.18	4.2	6.46%	95.94%
MRK	321.7B	60.1B	1.36%	9.00%	881.36	5.35	1.40%	-97.49%
PFE	148.3B	46.5B	-4.27%	-33.23%	-106.79	3.19	42.59%	-114.62%
AMGN	146.3B	28.2B	-2.78%	11.49%	21.78	5.19	7.09%	2.52%
GILD	83.6B	27.1B	-7.58%	-21.63%	14.75	3.08	-0.60%	23.36%
TEVA	14.6B	15.8B	-7.47%	58.08%	-25.3	0.92	6.17%	76.47%
MID-CAP
PRGO	4.2B	4.7B	0.71%	-13.71%	-333.24	0.91	4.58%	90.97%
ALKS	4.1B	1.7B	-9.74%	-19.21%	11.58	2.48	49.61%	324.78%
BHC	3.1B	8.8B	-9.70%	20.22%	-5.28	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-6.03%	4.38%	14.34	3.06	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	-14.42%	-17.86%	-4.05	1.92	24.65%	80.36%
TXMD	22.3M	1.3M	-15.72%	-46.54%	-2.17	17.09	-98.14%	-109.18%
ACRX	16.3M	-	-17.24%	40.47%	-0.89	0.22	2882.68%	-138.52%
AGRX	2.7M	19.6M	-33.33%	-94.15%	-0.19	0.14	80.00%	43.08%
ACOR	683.2K	117.6M	-96.48%	-95.45%	0	0.01	-0.79%	-283.60%

PetMed Express Inc News

Latest updates

PetMed Express Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-8.0%	65.00	71.00	78.00	62.00	59.00	65.00	70.00	66.00	61.00	67.00	79.00	72.00	66.00	75.00	96.00	74.00	60.00	70.00	80.00	65.00	60.00
Gross Profit	-10.9%	18.00	20.00	23.00	17.00	15.00	18.00	20.00	19.00	18.00	19.00	22.00	21.00	20.00	23.00	27.00	22.00	18.00	20.00	22.00	21.00	19.00
Operating Expenses	2.2%	21.00	21.00	25.00	24.00	16.00	15.00	16.00	12.00	13.00	11.00	16.00	12.00	10.00	13.00	17.00	13.00	10.00	12.00	16.00	13.00	10.00
S&GA Expenses	-100.0%	-	13.00	16.00	19.00	10.00	11.00	9.00	8.00	8.00	7.00	8.00	7.00	6.00	7.00	8.00	6.00	6.00	6.00	7.00	6.00	6.00
EBITDA Margin	-172.7%	-0.01*	0.00*	0.00*	0.02*	0.07*	0.09*	0.11*	0.11*	0.11*	0.12*	0.13*	0.13*	0.13*	-	-	-	-	-	-	-	-
Income Taxes	-236.4%	-0.62	0.00	-0.11	-0.91	0.00	1.00	1.00	1.00	1.00	2.00	1.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Earnings Before Taxes	-790.6%	-2.64	0.00	-1.00	-6.03	0.00	4.00	4.00	7.00	6.00	8.00	6.00	9.00	10.00	11.00	10.00	9.00	9.00	9.00	7.00	9.00	10.00
EBT Margin	-40.7%	-0.03*	-0.02*	-0.01*	0.01*	0.06*	0.08*	0.09*	0.10*	0.10*	0.11*	0.12*	0.13*	0.13*	-	-	-	-	-	-	-	-
Net Income	-2795.7%	-2.03	-0.07	-0.89	-5.10	-0.02	3.00	3.00	6.00	4.00	6.00	4.00	7.00	8.00	8.00	8.00	7.00	7.00	7.00	5.00	7.00	8.00
Net Income Margin	-29.9%	-0.03*	-0.02*	-0.01*	0.00*	0.04*	0.06*	0.07*	0.08*	0.08*	0.09*	0.09*	0.10*	0.10*	-	-	-	-	-	-	-	-
Free Cashflow	-111.0%	-3.72	-1.76	-0.59	8.00	12.00	-2.63	5.00	8.00	8.00	1.00	-0.90	18.00	6.00	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	8.8%	173	159	181	164	165	169	165	176	168	159	173	187	167	159	163	155	150	146	145	154	157
Current Assets	11.5%	96.00	86.00	106	131	134	138	134	151	143	133	147	161	141	133	136	129	123	118	117	126	128
Cash Equivalents	-7.5%	49.00	53.00	62.00	104	102	97.00	105	111	109	107	112	119	107	106	87.00	104	92.00	95.00	83.00	101	93.00
Net PPE	-0.6%	27.00	27.00	27.00	26.00	25.00	25.00	25.00	24.00	25.00	25.00	25.00	25.00	26.00	25.00	26.00	25.00	26.00	26.00	27.00	27.00	28.00
Goodwill	18.7%	27.00	22.00	21.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	60.7%	73.00	46.00	62.00	40.00	32.00	31.00	25.00	34.00	28.00	18.00	33.00	46.00	28.00	23.00	30.00	25.00	22.00	20.00	21.00	20.00	24.00
Current Liabilities	77.9%	72.00	41.00	57.00	36.00	31.00	31.00	24.00	33.00	26.00	16.00	32.00	45.00	27.00	21.00	29.00	24.00	21.00	19.00	20.00	19.00	23.00
Shareholder's Equity	-12.0%	100	114	98.00	124	134	0.00	0.00	130	0.00	0.00	132	141	133	131	128	130	125	2.00	122	135	12.00
Retained Earnings	-16.7%	77.00	92.00	98.00	105	117	123	127	130	131	133	132	134	133	131	128	126	125	123	122	122	121
Additional Paid-In Capital	7.8%	23.00	22.00	20.00	18.00	17.00	15.00	13.00	12.00	10.00	9.00	8.00	7.00	6.00	5.00	5.00	4.00	3.00	2.00	2.00	12.00	12.00
Shares Outstanding	0.1%	21.00	21.00	21.00	21.00	21.00	20.00	20.00	21.00	20.00	20.00	20.00	20.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	-	-	396	-	-	-	540	-	-	-	617	-	-	-	349	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-233.7%	-2,593	-777	562	9,724	12,971	-1,272	6,380	8,717	8,706	1,497	-422	18,449	6,438	26,390	-11,202	17,266	4,284	17,258	36.00	13,113	11,623
Share Based Compensation	-1.3%	1,707	1,729	1,760	1,613	1,770	1,681	1,536	1,509	1,440	882	718	1,013	781	773	740	741	716	730	635	785	812
Cashflow From Investing	-44.6%	-1,423	-984	-37,012	-1,931	-993	-1,354	-5,982	-486	-294	-495	-477	-584	-655	-1,048	-145	-484	-1,411	-224	-192	-113	-57.00
Cashflow From Financing	99.8%	-15.00	-6,302	-6,102	-6,135	-6,096	-6,242	-6,064	-6,062	-6,063	-6,226	-6,033	-5,648	-5,626	-5,819	-5,594	-5,394	-5,396	-5,535	-16,975	-5,637	-5,532
Dividend Payments	-100.0%	-	6,302	6,102	6,135	6,096	6,242	6,064	6,062	6,063	6,226	6,033	5,648	5,626	5,819	5,594	5,393	5,396	5,535	5,479	5,637	5,532
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	11,496	-	-

PETS Income Statement

2023-12-31

Condensed Consolidated Statements of (Loss) Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Sales	$ 65,317	$ 58,870	$ 214,560	$ 194,172
Cost of sales	47,434	43,632	154,089	140,819
Gross profit	17,883	15,238	60,471	53,353
Operating expenses:
General and administrative	13,425	10,425	41,098	29,669
Advertising	5,762	4,641	18,539	14,869
Depreciation and amortization	1,770	941	5,161	2,552
Total operating expenses	20,957	16,007	64,798	47,090
(Loss) income from operations	(3,074)	(769)	(4,327)	6,263
Other income:
Interest income, net	136	299	481	11
Other, net	293	259	1,053	718
Total other income	429	558	1,534	729
(Loss) income before provision for income taxes	(2,645)	(211)	(2,793)	6,992
(Benefit) provision for income taxes	(618)	1	(345)	1,636
Net (loss) income	$ (2,027)	$ (212)	$ (2,448)	$ 5,356
Net (loss) income per common share:
Basic (in dollars per share)	$ (0.10)	$ (0.01)	$ (0.12)	$ 0.26
Diluted (in dollars per share)	$ (0.10)	$ (0.01)	$ (0.12)	$ 0.26
Weighted average number of common shares outstanding:
Basic (in shares)	20,425,282	20,301,384	20,380,262	20,257,145
Diluted (in shares)	20,425,282	20,301,384	20,380,262	20,339,064
Cash dividends declared per common share (in dollars per share)	$ 0	$ 0.30	$ 0.60	$ 0.90

PETS Balance Sheet

2023-12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 49,440	$ 104,086
Accounts receivable, less allowance for doubtful accounts of $39 and $35, respectively	1,930	1,740
Inventories - finished goods, net	34,577	19,023
Prepaid expenses and other current assets	8,804	4,719
Prepaid income taxes	798	863
Total current assets	95,549	130,431
Noncurrent assets:
Property and equipment, net	26,811	26,178
Intangible and other assets, net	16,992	5,860
Goodwill	26,657	0
Operating lease right-of-use assets, net	1,626	0
Deferred tax assets, net	5,715	5,009
Total noncurrent assets	77,801	37,047
Total assets	173,350	167,478
Current liabilities:
Accounts payable	38,851	25,208
Sales tax payable	24,172	26,113
Accrued expenses and other current liabilities	5,557	6,191
Current lease liabilities	752	0
Deferred revenue	3,068	0
Total current liabilities	72,400	57,512
Long-term lease liabilities	890	0
Total liabilities	73,290	57,512
Commitments and contingencies (Note 9)
Shareholders' equity:
Preferred stock, $.001 par value, 5,000,000 shares authorized; 2,500 convertible shares issued and outstanding with a liquidation preference of $4 per share	9	9
Common stock, $.001 par value, 40,000,000 shares authorized; 21,160,739 and 21,084,302 shares issued and outstanding, respectively	21	21
Additional paid-in capital	23,473	18,277
Retained earnings	76,557	91,659
Total shareholders' equity	100,060	109,966
Total liabilities and shareholders' equity	$ 173,350	$ 167,478

About PetMed Express Inc

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

CEO	Mr. Mathew N. Hulett
WEBSITE	1800petmeds.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	302

PetMed Express Inc Frequently Asked Questions

What is the ticker symbol for PetMed Express Inc? What does PETS stand for in stocks?

PETS is the stock ticker symbol of PetMed Express Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of PetMed Express Inc (PETS)?

As of Wed Apr 24 2024, market cap of PetMed Express Inc is 86.97 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PETS stock?

You can check PETS's fair value in chart for subscribers.

What is the fair value of PETS stock?

You can check PETS's fair value in chart for subscribers. The fair value of PetMed Express Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of PetMed Express Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PETS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is PetMed Express Inc a good stock to buy?

The fair value guage provides a quick view whether PETS is over valued or under valued. Whether PetMed Express Inc is cheap or expensive depends on the assumptions which impact PetMed Express Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PETS.

What is PetMed Express Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, PETS's PE ratio (Price to Earnings) is -10.76 and Price to Sales (PS) ratio is 0.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PETS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on PetMed Express Inc's stock?

In the past 10 years, PetMed Express Inc has provided -0.075 (multiply by 100 for percentage) rate of return.